Dasatinib combined with weekly administration of vincristine as effective therapy in sudden or resistant Ph+ lymphoid blast crisis of chronic myeloid leukaemia

Br J Haematol. 2012 Dec;159(5):612-3. doi: 10.1111/bjh.12079. Epub 2012 Oct 9.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / administration & dosage*
  • Blast Crisis / drug therapy*
  • Dasatinib
  • Drug Administration Schedule
  • Female
  • Humans
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy*
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / pathology*
  • Middle Aged
  • Pyrimidines / administration & dosage
  • Pyrimidines / adverse effects
  • Thiazoles / administration & dosage
  • Thiazoles / adverse effects
  • Vincristine / administration & dosage
  • Vincristine / adverse effects

Substances

  • Pyrimidines
  • Thiazoles
  • Vincristine
  • Dasatinib